Antimicrobial resistance poses growing threat to global healthcare

Antimicrobial resistance is becoming an increasing challenge for global healthcare systems as bacteria, viruses, fungi, and parasites develop the ability to survive drugs that previously inhibited them. This resistance is a characteristic of the microorganisms themselves, often accelerated by the improper or excessive use of antimicrobial medications.

In clinical settings, the rise of resistant bacteria is forcing medical professionals to rely on third- and fourth-line antibiotics. Saša Srića, head of the Internal Medicine Department at KBC Zagreb, reported that approximately 25 percent of patients in his department currently harbor resistant bacteria. This trend affects various conditions, including respiratory and urinary tract infections, and necessitates more complex treatments and longer hospital stays.

The implications of losing antibiotic efficacy extend beyond treating simple infections. Modern medical procedures, such as surgeries, organ transplants, and certain cancer treatments, rely heavily on effective antibiotics to manage infection risks. Experts emphasize the importance of distinguishing between viral and bacterial infections to prevent the unnecessary use of antibiotics.